Pages
Outpatient Physiotherapy, Occupational Therapy and MSK Triage Service
https://dchs.nhs.uk/our-services-and-locations/a-z-list-of-services/msk-triage-derbyshire
Freedom to speak up animations
We have developed a series of animations based on issues staff have raised a concern about in DCHS. We hope they help you make your decision about whether you should raise a concern.
https://dchs.nhs.uk/my_dchs/how-do-i/freedom-to-speak-up/freedom-speak-animations
How does diversity affect the way our colleagues and patients experience health and health services?
Files
Guidance for the Dispensing of Aciclovir 400mg for HSV suppression in DCHS Integrated Sexual Health Service (S111)
S111 - Guidance for the Dispensing of Aciclovir 400mg for HSV suppression in DCHS Integrated Sexual Health Service
Protocol for the Administration of Lidocaine 10mg per ml Spray to Facilitate IUC Insertion or Removal
PGD Protocol for the Administration of Lidocaine 10mg per ml Spray to Facilitate IUC Insertion or Removal
Guidance for Wound Clinic Services for the use of tap water on chronic wounds (G308)
Guidance for Wound Clinic Services for the use of tap water on chronic wounds
Annual Leave Calculator 2024-2025
Annual Leave Calculator 2024-2025
DCHS Scheme Of Delegation
Scheme Of Delegation - April 2025
A2 - Catheter Clinical Appointment Letter (G324)
Catheter Clinical Appointment Letter
Disclosure Ref 2024131 - Cyber Security Attacks.pdf
FOI Disclosure Ref 2024131 relating to Cyber Security Attacks
Disclosure Ref 2024128 - Social Media Platforms.pdf
FOI Disclosure Ref 2024128 - Social Media Platforms
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates.pdf
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010